The leukotriene receptor antagonist montelukast as a potential therapeutic adjuvant in multiple sclerosis - a review
Multiple Sclerosis (MS) is a multifactorial autoimmune disease of the central nervous system (CNS). It is characterized by a heightened activation of the immune system with ensuing inflammation, demyelination and neurodegeneration with consequences such as motor, sensory, cognitive, as well as auton...
Saved in:
Main Authors: | Frank Pietrantonio (Author), Alex Serreqi (Author), Horst Zerbe (Author), Per Svenningsson (Author), Ludwig Aigner (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exercise-induced bronchoconstriction: The effects of montelukast, a leukotriene receptor antagonist
by: James P Kemp
Published: (2009) -
Role of Leukotriene receptor antagonist Montelukast in the treatment of chronic urticaria: A hospital based study
by: Iffat Hassan, et al.
Published: (2012) -
Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial
by: Eman El-Khateeb, et al.
Published: (2023) -
Effects of oral cysteine leukotriene receptor antagonist-montelukast on adenoid lymphoid tissue: a histopathological study under light microscope
by: Zhengying Wang, et al.
Published: (2023) -
Role of Leukotriene Receptor Antagonists in Asthma
by: Chih-Hsing Hung
Published: (2012)